NDC 70954-005-40 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70954-005
- Requested NDC
- 70954-005-40
- Package NDCs from labels
- 70954-005-10, 70954-005-20, 70954-005-30, 70954-005-40, 70954-005-50
- Manufacturer
- Northwind Health Company, LLC
- Effective date
- 2026-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - VERITYRX, LLC | VERITYRX, LLC | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Major Pharmaceuticals | Major Pharmaceuticals | 2025-09-19 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride Tablets, USP Rx only | Golden State Medical Supply, Inc. | 2024-12-23 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - ANI Pharmaceuticals, Inc. | Novitium Pharma LLC | ANI Pharmaceuticals, Inc. | Novitium Pharma LLC | 2024-11-25 | Human Prescription Drug Label |
| Oxybutynin Chloride Tablets, USP 5 mg Rx only | NuCare Pharmaceuticals,Inc. | 2024-08-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride Tablets, USP Rx only | REMEDYREPACK INC. | 2024-06-18 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - A-S Medication Solutions | A-S Medication Solutions | 2023-12-27 | Human Prescription Drug Label |
| Oxybutynin Chloride - A-S Medication Solutions | A-S Medication Solutions | 2023-12-27 | Human Prescription Drug Label |
| Oxybutynin Chloride - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2020-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Oxybutynin Chloride - Marlex Pharmaceuticals Inc | Marlex Pharmaceuticals Inc | 2019-10-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70954-005-10 | Oxybutynin Chloride | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 70954-005-20 | Oxybutynin Chloride | 500 in 1 BOTTLE | TABLET | 500 | 4 | |
| 70954-005-30 | Oxybutynin Chloride | 1000 in 1 BOTTLE | TABLET | 1000 | 4 | |
| 70954-005-40 | Oxybutynin Chloride | 1 in 1 BLISTER PACK | TABLET | 1 | 4 | |
| 70954-005-50 | Oxybutynin Chloride | 100 in 1 CARTON | TABLET | 100 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70954-005-10 | EA - Each | 70954-005 | 578dfbca-9e3c-4f4d-942f-e7a4d331a0dd | 1 | 2018-01-12 |
| 70954-005-20 | EA - Each | 70954-005 | ca724434-4206-4756-9065-a38e6252df49 | 1 | 2018-01-12 |
| 70954-005-30 | EA - Each | 70954-005 | ad034756-247c-496f-a21a-aae5cc3291d8 | 1 | 2018-01-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | TruPharma LLC | 7c497c6c-2448-2c80-e053-2991aa0ab8c7 | 2026-07-27 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | 9578b6b8-5b9d-4263-9142-39b2c7216b85 | 2026-07-21 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | ATLANTIC BIOLOGICALS CORP. | fe4ed76b-0009-455f-be30-47e80fc1afdf | 2026-07-09 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 55f618d1-4463-3200-e063-6394a90a89a8 | 2026-07-06 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | 9ede5def-d185-4e40-9c10-8663ac654caf | 2026-07-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | American Health Packaging | 0c71bdfb-01db-49ac-a8e9-0037df0d24af | 2026-06-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | ac10c7b7-d0cb-4068-93e2-c0e51f15866e | 2026-06-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 73d715dc-868d-4194-b668-4c39ababa698 | 2026-05-20 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | a5965c8b-179d-4665-8a3b-324b693607ee | 2026-05-19 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 7db4ab81-b379-4a6d-b469-95eb9e184b56 | 2026-05-14 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | American Health Packaging | 4574b227-9726-4798-bac2-83bfb9616f09 | 2026-04-16 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | b9d0e5c8-3a71-40a0-a7d3-44bc043392fa | 2026-02-17 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | a1f8be75-2eb9-4eef-8fb4-144ef2bf7ae1 | 2026-02-16 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 9a551ec5-7e80-47c9-a7b9-f458c1478174 | 2026-02-16 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Chartwell Governmental & Specialty RX, LLC. | 46e78c72-a5a3-472f-9125-b120fa4eee31 | 2026-01-30 | Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Advagen Pharma Limited | 7bd31561-4c76-4c6b-819b-492549886673 | 2026-01-14 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 3688227b-7655-40ca-b34b-073a39fd60f4 | 2026-01-14 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | f330b7a0-bbe0-0f00-e053-2a95a90a37b8 | 2026-01-01 | Warnings, Adverse reactions | ANDA209823 51655-665-52 51655-665-25 51655-665 863664 4950ae3a-d3c8-b948-e063-6394a90afa44 f330b7a0-bbe0-0f00-e053-2a95a90a37b8 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | 13a79659-a181-6a61-e063-6294a90ae034 | 2025-12-26 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.